Skip to page content

Cancer

Journal Article
End-of-Life Cost Trajectories in Cancer Patients Treated by Medicare Versus the Veterans Health Administration
To evaluate differences in end-of-life cost trajectories for cancer patients treated through Medicare versus by the Veterans Health Administration (VA).
Dec 30, 2020
Commentary
More Could Be Spent on Recruiting and Training Cancer Staff if the NHS Is to Provide a World-Class Cancer Service
Cancer is a leading cause of death in the UK. Action is needed now to recruit and train more NHS staff in certain key cancer-related roles if NHS is to meet its ambitions for improving cancer services over the next 10 years.
Dec 10, 2020
Journal Article
On the Value of the Umbilical Cord Blood Supply
Several public cord blood banks are struggling financially, and the question remains whether additional allocations of funds to them are justified. This article estimates the social benefits of public cord blood bank inventory net of cord blood banks' operational costs.
Nov 17, 2020
Journal Article
Estimating the Cost of Growing the NHS Cancer Workforce in England by 2029
This research aims to understand the requirements for the NHS, and particularly for HEE, of increasing the seven priority cancer workforces by 45 per cent by 2029.
Oct 14, 2020
Journal Article
The Complex Cancer Care Coverage Environment: What Is the Role of Legislation? A Case Study from Massachusetts
We identified five current cancer coverage state laws and interviewed experts on their perceptions of the relevance of the laws and how well they meet the current needs of cancer care given rapid changes in therapies.
Oct 13, 2020
Journal Article
Outcome-based Payment Schemes: What Outcomes Do Patients with Cancer Value?
A study exploring the feasibility of introducing OBP for new cancer medicines in the NHS, focusing on the kinds of outcomes that patients and their carers consider most important to refer to in this context.
Jul 22, 2020
Journal Article
Health System and Beneficiary Costs Associated With Intensive End-of-Life Medical Services
The objective of this paper is to quantify expected beneficiary and health system costs incurred in association with receipt of intensive medical services in the last month of life.
Mar 11, 2020
Report
Decision-making for investment in early diagnosis interventions for cancer: An interview-based study for Cancer Research UK
RAND Europe sought to better understand how commissioners of healthcare services and Cancer Alliances make decisions about early diagnosis interventions at a local level, with a particular focus on England and Northern Ireland.
Mar 2, 2020
Report
Industrial Cancers in California's Workers' Compensation System: Evidence on Earnings Losses and Disability Benefits
In this report, the authors conduct an empirical analysis of earnings losses, disability ratings, and benefit payments for occupational cancer claims in the California workers' compensation system.
Jan 31, 2020
Commentary
Treating Breast Cancer Is Not Just About the Disease: Its Wider Impacts Need to Be Considered, Too
Successes in the early treatment of breast cancer are to be celebrated. But those achievements need not limit the development of further and better treatment for patients. Understanding the disease's wider effects could help bring this about.
Oct 22, 2019
Report
Vitality Age with pre-existing conditions
The Vitality Age with pre-existing conditions (VAPC) is an extension to VA.3, allowing explicit differentiation between individuals with one or more selected pre-existing conditions that negatively affect their health and life expectancy.
Jun 25, 2019
Report
Factors affecting access to treatment of early breast cancer: Case studies from Brazil, Canada, Italy, Spain and UK: Implications for future research, policy and practice
RAND Europe conducted a study on the societal impact of early breast cancer, divided into three interconnected phases. The third phase was a qualitative study assessing the factors affecting access and delivery of treatment for early breast cancer.
Jun 11, 2019
Report
A Review of the Research Landscape for Treatment of Early Breast Cancer: Implications for future research, policy and practice
RAND Europe conducted a study on the societal impact of early breast cancer. This study was divided into three interconnected phases. The first phase was a mapping review on the published literature on the impacts of treatment of early breast cancer.
Jun 11, 2019
Report
Findings from a systematic review to explore the patient and societal impacts of disease progression in women who were treated for early breast cancer: Implications for future research, policy and practice
RAND Europe conducted a study on the societal impact of early breast cancer. This study was divided into three connected phases. The second phase was a systematic review on non-clinical outcomes of recurrence after treatment of early breast cancer.
Jun 11, 2019
Report
Understanding the societal impact of treatment of early breast cancer: What are the non-clinical outcomes associated with disease progression?
RAND Europe conducted a study on the societal impact of early breast cancer. This study was divided into three interconnected phases. This is the summary report of the cross-analysis of data gathered through the three phases.
Jun 11, 2019
Journal Article
Randomized Controlled Dissemination Study of Community-to-Clinic Navigation to Promote CRC Screening: Study Design and Implications
The purpose of this study is to extend the pilot study in a group-randomized controlled trial to test the effectiveness of tailored messaging delivered by Community Health Navigators to guide individuals from especially hard-to-reach, multicultural, and underinsured communities into primary care clinics for referral for CRC screening (Phase I) and to continue navigation after referral to track effects of the intervention on completion of CRC screening (Phase II).
Jun 11, 2019
Journal Article
The Problematic Economics of Integrative Oncology
The economics of integrative oncology are problematic because of the lack of good studies, the lack of historic incentives for efficiency, and the high cost of cancer care and its financial toxicity on patients. However, these problems can be overcome, with help from one good economic evaluation at a time.
Jun 11, 2019
Journal Article
Making Outcome-Based Payment a Reality in the NHS
A study exploring the feasibility of introducing OBP for new cancer medicines in the NHS, focusing on the kinds of outcomes that patients and their carers consider most important to refer to in this context.
Feb 21, 2019
Journal Article
Describing Care Coordination of Gynecologic Oncology in Western Healthcare Settings: A Rapid Review
This article discusses a rapid review of the literature on characteristics of care coordination for gynecologic malignancies.
Jul 6, 2018
Journal Article
Evaluating Integrative Cancer Clinics With the Claim Assessment Profile: An Example With the InspireHealth Clinic
This study demonstrated the feasibility of evaluating cancer clinical programs - which has proven challenging - using a new approach called the Claim Assessment Profile.
Apr 13, 2018

Previous
1
2
3
4
5
6
7
8
9
10
Next

RAND Topic:
Cancer

Topic Synonyms:
Carcinoma;
Neoplasms;
Oncology;
Sarcoma

Research conducted by

RAND Health Care

Researcher Spotlight

Natalie Ernecoff

Associate Policy Researcher

Natalie C. Ernecoff (she/her) is an associate policy researcher at the RAND Corporation. Her research focuses on developing, implementing, and evaluating systems-level palliative care, hospice, and home care interventions. Her work includes healthcare system informatics, electronic health record…
Ariella Korn

Associate Policy Researcher

Ariella Korn (she/her) is an associate policy researcher at the RAND Corporation. Her research aims to advance health equity by enhancing the reach and uptake of evidence-based practices, programs, and policies while incorporating a holistic view of context. Korn has expertise in social drivers…

Explore Our People »